Bladder Cancer Study Determines Optimal Treatment

	Tweet

Cancer specialists and researchers at Princess Margaret Hospital, University Health Network (UHN), are tackling an ongoing controversy about the best way to treat an aggressive form of bladder cancer – immediate radical surgery or a more conservative initial approach using immunotherapy?

To answer that question, Drs. Girish Kulkarni, Shabbir Alibhai and colleagues calculated the life expectancy and the quality of life expected from the two treatment methods. The team used a decision-analysis tool – the Markov model – a first for this form of bladder cancer. 

The results will be released Sept. 25 in PloS Medicine, the journal of the Public Library of Science, which is a peer-reviewed, open-access journal that publishes original research relevant to improving human health.

Cystectomy – the surgical removal of the bladder – is considered an excellent treatment to cure this form of bladder cancer. In some cases, a new bladder is fashioned from part of the bowel. In others, an opening is created to collect urine in a pouch outside the body. Immunotherapy uses bacillus Calmette-Guerin (BCG; the tuberculosis bacterium) to treat cancer cells directly in the bladder and avoids the need for a major operation. BCG stimulates an immune response that diminishes the risk of tumour recurrence and/or progression. The researchers compared the pros and cons of each treatment in their model.

The findings demonstrate that patients under the age of 60 who opt for immediate surgery can live longer with a higher quality of life than if they had chosen the more conservative option. On the other hand, the better choice for patients over age 70 with other health issues – or for those who place a high value on retaining sexual function and avoiding other side effects of surgery that may impair quality of life – was the more conservative initial approach using immunotherapy.

More importantly, the study identified the major quality of life factors that should be discussed with patients when choosing between these treatment options.

“Our findings highlight the trade-off that exists when deciding between radical surgery and a more conservative approach to treating this pre-invasive form of bladder cancer. The results of this study should help urologists to discuss the balance between quantity and quality of life, particularly with patients aged 60 to 70 years,” says PMH surgical oncologist Dr. Antonio Finelli, a co-investigator in the study.

“What may appear to be the most suitable treatment initially may not be the case when you consider other health issues and how well an individual will cope with effects of surgery that reduce their quality of life.”

The research was supported in part by the Canadian Institutes of Health Research and the National Cancer Institute of Canada.

Princess Margaret Hospital and its research arm, Ontario Cancer Institute, have achieved an international reputation as global leaders in the fight against cancer. Princess Margaret Hospital is a member of the University Health Network, which also includes Toronto General Hospital and Toronto Western Hospital. All three are research hospitals affiliated with the University of Toronto.

Source: University Health Network (UHN)

RELATED STORIES:
Certain Ecologic Factors Associated with Greater Risk of Bladder Cancer   Less bladder cancer in frequent painkiller users   Blood test may find markers of bladder cancer risk   Consumption of Cultured Milk Products May Reduce Bladder Cancer Risk   New made-in-Canada therapy for bladder cancer shows promising results   Thomas Jefferson University Hospital adopts new imaging agent to improve detection of bladder cancer   New Trial Targets Kidney Cancer Drug in Bladder Cancer   Survivors of Childhood Cancers Treated with Cyclophosphamide More Likely to Develop Bladder Cancer   Urinary tract cancer associated with Chinese herbal products containing aristolochic acid   Early menopause related to bladder cancer risk   Not enough evidence for bladder cancer screening   Bladder cancer: A difficult problem?   Retired firefighters could be at increased risk for developing bladder cancer   Protein Key to Bladder Cancer Spread, Potential Drug Target   Robotic Surgery Extends Benefits to Bladder Cancer Patients   Arsenic cancer risk still high decades later in Chile region   Patients unaware of link between smoking and bladder cancer   Scientists find one reason why bladder cancer hits more men   Measurement of Urinary Protein Can Help Detect Recurrent Bladder Cancer   Bladder cancer patients rarely receive recommended care   Researcher Says Improved Detection of Bladder Tumors Reduces Cancer Recurrence   Chemicals in meat may be linked to bladder cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]